SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending after confirming the REGAL trial has reached 78 of the 80 required clinical events, bringing the data unblinding milestone within reach. Community sentiment is highly polarized, with longs anticipating a major valuation re-rate and potential buyout while bears remain skeptical about trial success and trial timelines.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) remains a focal point for momentum traders as the community intensely debates its volatile, low-float potential for rapid price swings and short-squeeze dynamics. The conversation is dominated by comparisons to other active China-based microcaps, with many investors actively tracking the stock's frequent halts while debating the sustainability of its parabolic movement versus high-risk dilution concerns.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is generating intense market excitement as investors position themselves ahead of the Cerebras Systems IPO, viewing the company as a key infrastructure proxy for AI data center capacity. Community discussion is dominated by bullish sentiment regarding recent expansion contracts, with many participants actively dismissing short-term volatility as they target significant price appreciation.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing heightened volatility and investor scrutiny as the market weighs significant regulatory milestones, such as NRC design criteria approval, against concerns over the company's pre-revenue status and sustained insider selling. While some community members remain bullish on the long-term AI-driven energy thesis and potential for rapid scaling, others caution that the current valuation is speculative and disconnected from immediate commercial realities.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing intense volatility and downward pressure as investors grow skeptical of management's ability to convert defense partnerships and production capacity into immediate financial results ahead of the upcoming earnings release. The community remains divided, with some betting on a potential short squeeze fueled by significant short interest, while critics express frustration over the gap between the company's ambitious narrative and its historical revenue performance.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is trending as investors react to reports that Nelson Peltzs Trian Fund Management is seeking financing for a potential take-private bid, fueling community speculation about a significant short squeeze. Many participants are debating the viability of a buyout valuation while closely monitoring high short interest and the stocks historical trading patterns.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a surge in momentum as investors increasingly view the company as a key beneficiary of the massive power demands from AI data centers, mirroring the recent success of peers like Bloom Energy. The stock is seeing high trading volume and significant interest as the community focuses on the potential for new hyperscaler contracts to validate the company's modular power technology.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing significant upward price momentum driven by investor enthusiasm surrounding its solid-state battery technology and its strategic alignment with major material partners like Corning, which the community believes validates the company's potential in the AI data center and energy storage sectors. While there is no official news release, traders are actively speculating on a potential short squeeze, citing high short interest and institutional accumulation as catalysts for a larger breakout.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is attracting significant investor attention driven by a mix of positive earnings momentum, a growing defense backlog, and persistent speculation regarding its role in the space supply chain. The community remains deeply divided, with bulls highlighting the stock's potential as a play on additive manufacturing's critical role in aerospace and defense, while bears point to ongoing concerns regarding cash burn, dilution, and high short interest.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a persistent value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over share price weakness and perceived market manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of -48.24% and -12.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) Misses Q1 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of -5.09% and -1.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

Relay Therapeutics (RLAY) delivered earnings and revenue surprises of -18.84% and -80.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Harrow (HROW) Projected to Post Quarterly Earnings on Monday

Harrow (NASDAQ:HROW) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at...

Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Harrow, Inc. (NASDAQ:HROW) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Harrow, Inc. (NASDAQ:HROW - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have...

Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research

BTIG Research restated a "buy" rating and set a $63.00 price objective on shares of Harrow in a research report on Friday...

LogiCare3PL Selected as Distribution Partner by Harrow

LogiCare3PL Selected as Distribution Partner by Harrow LogiCare3PL Selected as Distribution Partner by Harrow PR Newswire OLIVE BRANCH, Miss., April 14, 2026 OLIVE BRANCH, Miss., April 14, 2026 /PRNewswire/ -- LogiCare3PL today announced it has been selected by Harrow, Inc. (Nasdaq: HROW) as a...

Jefferson Bridge Capital LLC Buys Shares of 52,798 Harrow, Inc. $HROW

Jefferson Bridge Capital LLC bought a new stake in Harrow, Inc. (NASDAQ:HROW - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The...

Harrow, Inc. (NASDAQ:HROW) Given Average Recommendation of "Moderate Buy" by Brokerages

Harrow, Inc. (NASDAQ:HROW - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat Ratings reports. One...

$HROW Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.74 down -48.00% YoY
• Reported revenue of $44.2M down -7.59% YoY
• Harrow reaffirmed its full-year 2026 revenue guidance at $350M to $365M and expects second quarter revenue between $71 million and $81 million for Harrow.

Stocktwits

Harrow Health Inc

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.74 down -48.00% YoY
• Reported revenue of $44.2M down -7.59% YoY
• Harrow reaffirmed its full-year 2026 revenue guidance at $350M to $365M and expects second quarter revenue between $71 million and $81 million for Harrow.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Current Price	$29.03
Prev Close	$38.04
Open	$33.87
Dividend Yield	0.00%
50-Day Moving Average	$37.64
Beta	1.46
Avg. Volume	479,214.15
PE Ratio	-232.66

52-Week High	$54.85
52-Week Low	$24.62
Market Capitalization	$1.42B
EPS (Annual)	-$0.1398
Price to Book	27.00
Revenue Per Employee	$730,034.85

HROW
Harrow Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HROW News

HROWHarrow Health Inc